Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 227-237

  Boonjaraspinyo, Sirintip ^a,b   Boonmars, Thidarut ^a,b   Kaewkes, Sasithorn ^a   Laummaunwai, Porntip ^a   Pinlaor, Somchai ^a,b   Loilome, Watchalin ^a,b   Yongvanit, Puangrat ^a,b   Wu, Zhiliang ^c   Puapairoj, Anucha ^b   Bhudhisawasdi, Vajarabhongsa ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Cholangiocarcinoma; Clinicopathology; Cyclin D1; Heat shock protein 70; Heat shock protein 90; Histone deacetylase 6; Retinoblastoma 1

Indexed keywords

CYCLIN D1; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE 6; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CYCLIN D1; DOWN-REGULATION; FEMALE; HISTONE DEACETYLASES; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84863493194     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9432-5     Document Type: Article

References (46)

1. International Agency for Research on Cancer (IARC) (1994) Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum 61:121-175
2. Sithithaworn P, Haswell-Elkins MR (2003) Epidemiology of Opisthorchis viverrini. Acta Trop 88:187-194
3. Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24:349-156
4. Freeman BC, Yamamoto KR (2002) Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296:2232-2235
5. Beere HM, Wolf BB, Cain K et al (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2:469-475
6. Madhavan J, Ganesh A, Kumaramanickavel G (2008) Retinoblastoma: from disease to discovery. Ophthalmic Res 40:221-226
7. Das SK, Hashimoto T, Shimizu K et al (2005) Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1 2. Biochim Biophys Acta 1726:328-335
8. Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761
9. Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26:5420-5432
10. Hideshima T, Bradner JE, Wong J et al (2005) Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A 102:8567-8572
11. DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755-762
12. Kondo S, Takada T, Miyazaki M et al (2008) Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 15:41-54
13. Uttaravichien T, Bhudhisawasdi V, Pairojkul C et al (1999) Intrahepatic cholangiocarcinoma in Thailand. J Hepatobiliary Pancreat Surg 62:128-135
14. Green A, Uttaravichien T, Bhudhisawasdi V et al (1991) Cholangiocarcinoma in north east Thailand: a hospital-based study. Trop Geogr Med 43:193-198
15. Boonmars T, Wu Z, Boonjaruspinyo S et al (2009) Alterations of gene expression of RB pathway in Opisthorchis viverrini infectioninduced cholangiocarcinoma. Parasitol Res 105:1273-1281
16. Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer, 2th ed. Tokyo: Kanehara 15
17. Nakanuma Y, Sripa B, Batanasapt V et al (2000) Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours: pathology and genetics - tumours of the digestive system. IARC Press, Lyon, pp 173-180
18. Edge SB, Byrd DR, Compton CC et al (2009) AJCC cancer staging manual, 7th edn. Springer-Verlag Press, New York
19. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103
20. Chuma M, Sakamoto M, Yamazaki K et al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37:198-207
21. Lazaris AC, Chatzigianni EB, Panoussopoulos D et al (1997) Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 43:43-51
22. Nanbu K, Konishi I, Komatsu T et al (1996) Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 77:330-338
23. Abd el All H, Rey A, Duvillard P (1998) Expression of heat shock protein 70 and c-myc in cervical carcinoma. Anticancer Res 18:1533-1536
24. Aghdassi A, Phillips P, Dudeja V et al (2007) Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res 67:616-625
25. Basso AD, Solit DB, Chiosis G et al (2002) Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem 277:39858-39866
26. Vanden Berghe T, Kalai M, van Loo G et al (2003) Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J Biol Chem 278:5622-5629
27. Chen G, Cao P, Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9:401-410
28. Jameel A, Skilton RA, Campbell TA et al (1992) Clinical and biological significance of HSP89 alpha in human breast cancer. Int J Cancer 50:409-415
29. Yano M, Naito Z, Yokoyama M et al (1999) Expression of Hsp90 and cyclin D1 in human breast cancer. Cancer Lett 137:45-51
30. Liu X, Ye L, Wang J et al (1999) Expression of heat shock protein 90 beta in human gastric cancer tissue and SGD7901/VCR of MDRtype gastric cancer cell line. Chin Med J (Engl) 112:1133-1137
31. Ogata M, Naito Z, Tanaka S et al (2000) Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma. J Nippon Med Sch 67:177-185
32. Cardillo MR, Sale P, Di Silverio F (2000) Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res 20:4579-4583
33. Bosco EE, Wang Y, Xu H et al (2007) The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest 117:218-228
34. Contu SS, Contu PC, Damin DC et al (2007) pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus. World J Gastroenterol 13:1728-1731
35. Chim CS, Wong KY, Loong F et al (2007) Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Hum Pathol 38:1849-1857
36. Chatterjee SJ, Datar R, Youssefzadeh D et al (2004) Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22:1007-1103
37. Sgambato A, Migaldi M, Faraglia B et al (2002) Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97:671-678
38. Deeb KK, Michalowska AM, Yoon CY et al (2007) Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 67:8065-8080
39. Kang YK, Kim WH, Jang JJ (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 33:877-888
40. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y et al (2003) Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 22:8723-8730
41. Kella VK, Constantine R, Parikh NS et al (2009) Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions - case report and review of literature. World J Surg Oncol 7:60
42. Gillett C, Smith P, Gregory W et al (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69:92-99
43. Azechi H, Nishida N, Fukuda Yet al (2001) Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 60:346-354
44. Mitra AP, Datar RH, Cote RJ (2006) Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24:5552-5564
45. Garcea G, Neal CP, Pattenden CJ et al (2005) Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41:2213-2236
46. Zhang Z, Yamashita H, Toyama T et al (2004) HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res 10:6962-6968